Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Canaccord Genuity Downgrades T2 Biosystems to Hold, Adjusts Price Target to $2.5

Canaccord Genuity analyst Kyle Mikson downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Hold and adjusts the price target from $12.5 to $2.5.
byBenzinga Newsdesk
October 14, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Canaccord Genuity analyst Kyle Mikson downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Hold and adjusts the price target from $12.5 to $2.5.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0